SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-041618
Filing Date
2022-07-26
Accepted
2022-07-26 13:32:39
Documents
14
Period of Report
2022-07-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea163353-8k_inmedpharma.htm   iXBRL 8-K 29874
2 NEWS RELEASE, DATED JULY 25, 2022 ea163353ex99-1_inmedpharma.htm EX-99.1 24350
6 GRAPHIC ex99-1_001.jpg GRAPHIC 4933
  Complete submission text file 0001213900-22-041618.txt   240081

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20220725.xsd EX-101.SCH 2965
4 XBRL LABEL FILE inm-20220725_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20220725_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea163353-8k_inmedpharma_htm.xml XML 3612
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221106112
SIC: 2834 Pharmaceutical Preparations